Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery

Autor:	Linea Cecilie Melchior, Jonathan Frederik Carlsen, E. Urbanska, Jens Benn Sørensen, Eric Santoni-Rugiu
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	Pulmonary and Respiratory Medicine Oncology Alectinib Cancer Research medicine.medical_specialty Brigatinib business.industry medicine.medical_treatment Whole brain radiotherapy medicine.disease Radiosurgery Discontinuation Second line Internal medicine medicine Non small cell Lung cancer business
Zdroj:	Urbanska, E M, Santoni-Rugiu, E, Melchior, L C, Carlsen, J F & Sørensen, J B 2021, ' Intracranial Response of ALK + Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery ', Clinical Lung Cancer, vol. 22, no. 4, pp. e528-e532 . https://doi.org/10.1016/j.cllc.2020.04.012
DOI:	10.1016/j.cllc.2020.04.012
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecff3da66a5aaf442d0368a7f30bb832 https://curis.ku.dk/ws/files/279191393/PIIS1525730420301352.pdf Zobrazit plný text záznamu